Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 113Neoplasm Metastasis 5Carcinoma, Intraductal, Noninfiltrating 5Polycystic Ovary Syndrome 4Ovarian Neoplasms 4Osteoporosis 4Neoplasms 4Infertility 4Breast Neoplasms, Male 4Arthralgia 4Fallopian Tube Neoplasms 3Triple Negative Breast Neoplasms 2Pain 2Leiomyosarcoma 2Leiomyoma 2Endometrial Neoplasms 2Cystadenocarcinoma, Serous 2Breast Carcinoma In Situ 2Bone Diseases, Metabolic 2Advanced Breast Cancer 2Uterine Neoplasms 1Recurrence 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Cysts 1Osteitis Deformans 1Obesity 1Multiple Endocrine Neoplasia Type 1 1Medullary cystic kidney disease 1 1Lymphoma, Non-Hodgkin 1

Interventions

Dexamethasone 43Cyclophosphamide 38fludarabine phosphate 27Cytarabine 26Rituximab 24Methotrexate 21Lenalidomide 21Bortezomib 21Calcium Dobesilate 20fludarabine 19Peripheral Blood Stem Cell Transplantation 19Whole-Body Irradiation 16Mycophenolic Acid 16pembrolizumab 15Gemcitabine 15Etoposide 15pomalidomide 14Melphalan 14Vincristine 13Filgrastim 13Busulfan 13Tacrolimus 12Cyclosporine 12Carboplatin 12Paclitaxel 11carfilzomib 10durvalumab 9Doxorubicin 9Cetuximab 9Brentuximab Vedotin 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Recurrence × Letrozole × Clear all
NCT01068249 2026-04-30

Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
42 enrolled 11 charts
Gynecologic

Recurrence, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡